Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 30121 - 30140 of 44495
Early Termination Notices

20021128: Scottish Power plc; Aquila, Inc.

… 20021128: Scottish Power plc; Aquila, Inc. HSR Early Termination Notice 20021128: Scottish Power plc; Aquila, Inc. 20021128 Aquila Merchant Services, Inc. Aquila Storage …
Date
Acquiring Party
Scottish Power plc
Acquired Party
Aquila, Inc.
Acquired Entities
Aquila Merchant Services, Inc.
Aquila Storage and Transportation, L.P.
Early Termination Notices

20021101: William H. Gates, III; Six Flags, Inc.

… 20021101: William H. Gates, III; Six Flags, Inc. HSR Early Termination Notice 20021101: William H. Gates, III; Six Flags, Inc. 20021101 Six Flags, Inc. Six Flags, Inc. William H. …
Date
Acquiring Party
William H. Gates, III
Acquired Party
Six Flags, Inc.
Acquired Entities
Six Flags, Inc.
Federal Register Notice

Conoco Inc. And Phillips Petroleum Company; Analysis to Aid Public Comment

… Conoco Inc. And Phillips Petroleum Company; Analysis to Aid Public Comment Federal Register Notice Conoco Inc. And Phillips Petroleum Company; Analysis to Aid Public Comment 021 0040 020909conocoincphillipspetroleum.pdf … Conoco Inc. And Phillips …
Date
Cases and Proceedings

Amgen Inc. and Immunex Corporation

… Amgen Inc. and Immunex Corporation Amgen Inc. and Immunex Corporation Amgen settled antitrust charges … would reduce competition and tend to create a monopoly in the biopharmaceutical markets for neutrophil (white blood …

Amgen settled antitrust charges that its proposed $16 billion acquisition of Immunex Corporation would reduce competition and tend to create a monopoly in the biopharmaceutical markets for neutrophil (white blood cell) regeneration factors; tumor necrosis factor (TNF) inhibitors; and interleukin-1 (IL-1) inhibitors. The consent order requires the firms to sell all of Immunex's assets related to Leukine -a neutrophil regeneration factor -to Schering AG; license certain intellectual property rights to TNF inhibitors to Serono S.A.; and license certain intellectual property rights related to IL-1 inhibitors to Regeneron Pharmaceuticals Inc.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210059
Docket Number
C-4056
HSR Informal Interpretations

0209001 Informal Interpretation

… 0209001 Informal Interpretation 0209001 Informal Interpretation September 4, … Exemption Dear Mr. Shape: This letter is to confirm the substance of our telephone discussion on August 30, 2002, regarding the application of the "Ordinary Course of Business …
Date
Rule
802.1(c) Current Supplies
No phone number to call back (Redacted). This is exempt in the ordinary course of business 802.1(c). 9/5/02. On 9/5/02 I talked to (Redacted). I concur with letter. PS
Amicus Briefs

Powers v. Harris

… Powers v. Harris Powers v. Harris Memorandum of the Federal Trade Commission, as amicus curiae, submitted to … States District Court for the Western District of Oklahoma, in a case challenging Oklahoma state restrictions on the sale of caskets. The …
Date
Citation Number
CIV-01-445-F
Memorandum of the Federal Trade Commission, as amicus curiae, submitted to the United States District Court for the Western District of Oklahoma, in a case challenging Oklahoma state restrictions on...
Early Termination Notices

20021124: AMERIGROUP Corporation; Miguel B. Fernandez

… AMERIGROUP Corporation; Miguel B. Fernandez HSR Early Termination Notice 20021124: AMERIGROUP Corporation; Miguel B. Fernandez 20021124 PHP Holdings, Inc. Miguel B. Fernandez AMERIGROUP Corporation … 20021124: …
Date
Acquiring Party
AMERIGROUP Corporation
Acquired Party
Miguel B. Fernandez
Acquired Entities
PHP Holdings, Inc.
Displaying 30121 - 30140 of 44495
Return to top